PharmaMar (Spain)
In research, PharmaMar (Spain) stands highest in Medicine (#15,987 of 17,978 worldwide), Life Sciences (#12,768 of 14,347 worldwide) and Health Sciences (#18,904 of 20,462 worldwide), over all time.
- World rank, all time
- #27,925 of 42,892
- Rank in Spain
- #663 of 927
- Research works
- 337 ▼ 42% vs 2013–17
- Citations
- 8.9k 26.3 per fractional work
- Top-10% rate
- 9.4% record average 16.5%
- Open access
- 30% world 28%
What is PharmaMar (Spain) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #15,987 of 17,978 | 12.9% | 128 | |
| Life SciencesDomain | #12,768 of 14,347 | 12.1% | 156 | |
| Health SciencesDomain | #18,904 of 20,462 | 13.1% | 130 | |
| Biochemistry, Genetics and Molecular BiologyField | #7,594 of 7,814 | 12.6% | 135 |
Each strip is that field’s whole ranked pool, with the notch where PharmaMar (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.4×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 4.4×
- Immunology and Microbiology 4.2×
- Biochemistry, Genetics and Molecular Biology 4.0×
- Medicine 3.1×
- Chemistry 2.9×
- Veterinary 1.2×
- Mathematics 0.8×
- Economics, Econometrics and Finance 0.6×
- Psychology 0.3×
- Agricultural and Biological Sciences 0.3×
- Earth and Planetary Sciences 0.2×
- Physics and Astronomy 0.1×
- Computer Science 0.1×
- Materials Science 0.1×
- Energy 0.1×
- Environmental Science 0.1×
- Neuroscience 0.1×
- Engineering 0.1×
Who are the top researchers at PharmaMar (Spain)?
Ranked on the composite score, Carlos M. Galmarini, José Jimeno and Pablo Avilés lead among researchers whose main affiliation is PharmaMar (Spain).
- 1 Carlos M. Galmarini Spain · #84,547 worldwide 229 citations · 40 works
- 2 José Jimeno Spain · #671,381 worldwide 51 citations · 24 works
- 3 Pablo Avilés Spain · #854,533 worldwide 16 citations · 19 works
- 4 Antonio Martínez Nieto Spain · #1,003,272 worldwide 2 citations · 66 works
- 5 Pilar Lardelli Spain · #1,070,538 worldwide 32 citations · 17 works
- 6 Carmen Cuevas Spain · #1,168,225 worldwide 47 citations · 30 works
- 7 María José Guillén Spain · #1,191,369 worldwide 8 citations · 17 works
- 8 Juan Fernando Martínez-Leal Spain · #1,256,159 worldwide 20 citations · 16 works
- 9 Carmen Kahatt Spain · #1,451,281 worldwide 23 citations · 24 works
- 10 Rogelio Fernández Spain · #1,543,905 worldwide 10 citations · 28 works
Which keywords describe research at PharmaMar (Spain)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Targeted Therapy, Immunotherapy, Biomarkers, Prognostic Factors, Metastasis and Genomic Profiles.
- Precision Medicine
- Pancreatic Neuroendocrine Tumors
- Neuroendocrine Tumors
- Inappropriate Medication Use
- Metabolic Syndrome
- Hematological Malignancies
- Topoisomerases
- DNA
- EGFR Mutations
- Secondary Metabolites
- Genome Sequencing
- Cancer
- Marine Natural Products
- Cancer Therapy
- Genomic Profiles
- Prognostic Factors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- Immunotherapy
- Biomarkers
- Metastasis
- Small-Cell Lung Cancer
- Drug Discovery
- Genomic Profiling
- Genetic Mutations
- Natural Products
- ALK Inhibitors
- Inflammation
- Pharmacology
- Tumor Microenvironment
- Anticancer Agents
- Survival Analysis
- Medicinal Chemistry
- PET Imaging
- Polypharmacy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 36 words, with their numbers
- Chemotherapy6▲ 27×10 topics
- Clinical Trials6▲ 24×7 topics
- Immunotherapy5▲ 19×8 topics
- Targeted Therapy5▲ 61×4 topics
- Biomarkers4▲ 18×10 topics
- Prognostic Factors4▲ 25×5 topics
- Metastasis3▲ 30×4 topics
- Genomic Profiles3▲ 194×1 topic
- Small-Cell Lung Cancer3▲ 194×1 topic
- Cancer Therapy3▲ 14×9 topics
- Drug Discovery2▲ 33×3 topics
- Marine Natural Products2▲ 169×2 topics
- Genomic Profiling2▲ 62×2 topics
- Cancer2▲ 4.0×13 topics
- Genetic Mutations2▲ 12×5 topics
- Genome Sequencing2▲ 34×2 topics
- Natural Products2▲ 35×1 topic
- Secondary Metabolites2▲ 68×1 topic
- ALK Inhibitors2▲ 79×1 topic
- EGFR Mutations2▲ 79×1 topic
- Inflammation2▲ 2.4×11 topics
- DNA1▲ 228×1 topic
- Pharmacology1▲ 17×5 topics
- Topoisomerases1▲ 228×1 topic
- Tumor Microenvironment1▲ 9.4×6 topics
- Hematological Malignancies1▲ 97×2 topics
- Anticancer Agents1▲ 22×4 topics
- Metabolic Syndrome1▲ 3.9×5 topics
- Survival Analysis1▲ 11×2 topics
- Inappropriate Medication Use1▲ 68×1 topic
- Medicinal Chemistry1▲ 11×2 topics
- Neuroendocrine Tumors1▲ 90×1 topic
- PET Imaging1▲ 18×4 topics
- Pancreatic Neuroendocrine Tumors1▲ 90×1 topic
- Polypharmacy1▲ 68×1 topic
- Precision Medicine1▲ 6.3×5 topics
Which research topics does PharmaMar (Spain) publish most on?
By volume in 2022–2025: Lung Cancer Research Studies, Microbial Natural Products and Biosynthesis, Lung Cancer Treatments and Mutations and Cancer therapeutics and mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Research Studies Oncology 3 works
- 2 Microbial Natural Products and Biosynthesis Pharmacology 2 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 4 Cancer therapeutics and mechanisms Molecular Biology 1 works
- 5 Neuroendocrine Tumor Research Advances Epidemiology 1 works
- 6 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 1 works
- 7 Peptidase Inhibition and Analysis Oncology 1 works
- 8 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 9 Synthesis and biological activity Organic Chemistry 1 works
- 10 Neutropenia and Cancer Infections Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has PharmaMar (Spain)'s research output changed?
Output in 2018–2022 was 42% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Madrid
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
- Hospital Universitario La Paz
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.